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ABSTRACT: Paroxetine HCl can exist as a nonstoichiometric hydrate
(Form II) or as a stoichiometric hemihydrate (Form I); the latter is
considered to be the stable form and its structure is well-known. However,
little work has been performed to investigate its dehydration behavior; hence,
the generation of the anhydrous form via dehydration of Form I was
investigated. A combination of thermal (diﬀerential scanning calorimetry
(DSC) and thermogravimetric analysis (TGA)) and diﬀraction (variable-
temperature X-ray powder diﬀraction (VT-XRPD)) techniques was used.
Dehydrated Form I was prepared using ultradry conditions, and the resulting
product was compared to dehydrated Form II. DSC indicated that the two dehydrated forms of Forms I and II had distinct
melting points. TGA experiments allowed the calculation of the activation energy for the dehydration of Form I, which varies
between 86 and 114 kJ/mol. Pawley reﬁnement of the VT-XRPD data suggested that Form I dehydrates to an isostructural
anhydrate, since the unit cell parameters of this new form were very similar to those of Form I with only a smaller volume as a
consequence of dehydration. Comparison with dehydrated Form II indicated that these two forms represent diﬀerent crystal
entities; hence, a new anhydrous form of paroxetine HCl has been identiﬁed.
■ INTRODUCTION
Hydrates are often the most physically stable form of an active
pharmaceutical ingredient (API) under conditions of relative
humidity (RH) typically found on storage; hence, their use
remains extremely widespread. Nevertheless, their dehydration
and rehydration behavior is often complex, with multiple forms
possible, which render thorough investigation of such
interchanges necessary for both practical and regulatory
reasons. The dehydration process occurs when the water
activity of the surrounding environment is lower than the water
activity in the solid compound.1 Once the water is removed
from the crystal structure packing, a range of structural
consequences may occur:2
(a) breakage of the crystal lattice, followed by a rearrange-
ment into a new anhydrous form;3
(b) the crystal structure remains the same after dehydration,
forming an isomorphic/isostructural dehydrate;4−8
(c) a partially or totally disordered state, followed by a
collapse into an amorphous phase.9,10
Isostructural dehydrates (b) are associated with high free
energy, which may be reduced by reincorporation of solvent
molecules into the lattice, rendering these types of compounds
highly hygroscopic.11 Dehydration is not always a straightfor-
ward process, and a mix of phases can be obtained with a
combination of more than one of the aforementioned
mechanisms taking place. An example is the case of eprosartan
mesylate dihydrate whereby, after losing the ﬁrst water
molecule, the monohydrate dehydrates and collapses into an
amorphous state, followed by recrystallization into an anhydrate
form of eprosartan mesylate.12 Another case is the dehydration
of trehalose dihydrate whereby the product obtained is highly
dependent on the dehydration conditions employed.13 More
speciﬁcally, fast dehydration produces an amorphous phase,
whereas a slow dehydration produces a crystalline phase (α-
polymorph) of anhydrous trehalose.
Thermal analysis techniques such as diﬀerential scanning
calorimetry (DSC) and thermogravimetric analysis (TGA) are
widely used to evaluate the dehydration behavior and the solid
state stability of pharmaceutical hydrates. Experiments can be
set isothermally or nonisothermally, and kinetic analysis can be
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performed by using either model-ﬁtting or model-free methods.
Model-ﬁtting methods involve expressions to which the
experimental data (isothermal or nonisothermal) are ﬁtted.
Model-ﬁtting methods assume a single value of activation
energy (Ea, the potential energy barrier that must be overcome
for the desolvation process to proceed) for the overall reaction
process, thereby implying a single reaction mechanism, and do
not provide an adequate interpretation of complex kinetic
reactions.14 On the other hand, model-free methods, as the
designation implies, are applied without any mechanistic
assumptions and, therefore, irrespectively of the underlying
reaction process. As a result, they are capable of quantifying Ea
at each conversion fraction, α, allowing both the detection of
multistep processes and the extraction of mechanistic
conclusions.15
Paroxetine hydrochloride (HCl) Form I is a stoichiometric
hydrate with half a mole of water per mole of drug, as shown by
its chemical structure in Figure 1.
Barnes et al.16 reported the preparation of Form I and
described this form as being extremely stable, with the removal
of the water from the crystalline structure being possible under
extreme desiccant conditions, with a quick rehydration to the
hemihydrate form.
Though the crystal structure of paroxetine HCl Form I is
now well-known,17 an important gap in the understanding of
this form is related to its dehydration behavior.18 The water
molecules in Form I are involved in three strong hydrogen
bonds, formed with two chloride ions and with a protonated
ammonium nitrogen, respectively, explaining the observed
stability of Form I (Figure 2).7,17 The overall hydrogen bond
network comprises extended ribbons along the monoclinic b
axis. Adjacent ribbons are separated by the hydrophobic rings
of the molecules, thereby forming hydrophilic “channels” across
the structure. Note, however, that there are no continuous
water channels in the structure, which would allow the escape
of the water molecules without a structural rearrangement.
Paroxetine HCl can also exist in Form II, which we recently
identiﬁed as being a nonstoichiometric hydrate (Figure 3).7,19
In this structure, the water molecules form only one strong
hydrogen bond with a chloride ion and a weak bond with a
dioxole oxygen atom. Although the water molecules do not
form continuous channels, only weak van der Waals
interactions need to be broken to create an opening between
adjacent water sites. Accordingly, Form II retains the same
crystal structure when dehydrated, undergoing gradual
expansion and contraction on exposure to diﬀerent water
activity conditions.
In an eﬀort to better understand the interplay between
hydrated and anhydrous forms of paroxetine HCl, a thorough
investigation into the dehydration behavior of Form I was
carried out using a combination of thermoanalytical techniques
(standard diﬀerential scanning calorimetry (DSC), modulated
temperature DSC (MTDSC), and thermogravimetric analysis
(TGA)) and high-resolution variable-temperature X-ray
powder diﬀraction (VT-XRPD). The water content of Form I
was determined by Karl Fischer titrimetry (KFT), and the
purity of the sample obtained after the dehydration of Form I
was determined using high-performance liquid chromatography
(HPLC). Additionally, the Ea needed to dehydrate Form I was
calculated using nonisothermal model-free (Ozawa−Flynn−
Wall) approaches. Our intention is to examine whether
dehydration from two signiﬁcantly distinct hydrate forms
leads to the same anhydrate for this material. This question is
particularly pertinent given the unusual nature of the
nonstoichiometric Form II and, as will be shown, the very
unstable nature of the Form I anhydrate; hence, little precedent
exists to determine whether the Form I (hemihydrate) will
yield the same dehydrated form.
■ EXPERIMENTAL SECTION
Materials. Paroxetine HCl Form I (purity of 99.5%) was purchased
from Aﬁne (China) and was used as received or after being kept over
phosphorus pentoxide (P2O5), Alfa Aesar (U.K.), or in a static oven, as
stated.
Methods. Thermal Analysis. Standard diﬀerential scanning
calorimetry (DSC, Q2000 TA Instruments, USA) analysis was
performed at heating rates of 2, 5, 10, 20, and 50 °C/min. Modulated
temperature DSC (MTDSC, Q2000 TA Instruments, USA) analysis
was conducted using a heating rate of 2 °C/min, an amplitude of
±0.318 °C, and a period of 60 s. The particle size of Form I was
controlled, and a size fraction of 63−106 μm was used. Scans were
carried out within the temperature range 0−170 °C. Pinhole,
Figure 1. Chemical structure of paroxetine HCl Form I.
Figure 2. Crystal structure of paroxetine HCl Form I.
Figure 3. Crystal structure of paroxetine HCl Form II.
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hermetically sealed, and open pans (pinhole pans without lid) were
used as stated. Nitrogen purge was used for all the DSC experiments
with a ﬂow rate of 50 mL/min. Calibration was performed using n-
octadecane, benzoic acid, indium, and tin.
Thermogravimetric analysis (TGA, Q5000 TA Instruments, USA)
was performed in aluminum open pans by weighing approximately 5
mg of Form I with a controlled particle size between 63 and 106 μm.
Nitrogen purge gas at a constant rate of 25 mL/min was maintained
during each run. Nonisothermal experiments were performed at
heating rates of 1, 2, 3, 4, and 5 °C/min from 30 °C until 300 °C.
Isothermal studies were carried out at 75, 80, 85, 90, and 95 °C with
Form I having been rapidly heated to the set temperature at 50 °C/
min and kept isothermal until a constant weight change was achieved.
Isothermal and nonisothermal data were used to calculate the
conversion fraction (α) as a function of time (αt) or temperature (αT),
as shown by eqs 1 and 2, respectively
α = −
− ∞
m m
m mt
t0
0 (1)
where m0 is the initial sample weight, mt is the sample weight at the
time, t, and m∞ is the ﬁnal sample weight
α = −
− ∞
m m
m mT
T0
0 (2)
where mT is the sample weight at temperature, T.
Karl Fischer Titrimetry (KFT). KFT (DL38, Mettler Toledo, U.K.)
for water determination of Form I was carried out by weighing
approximately 40−50 mg of the untreated bulk sample.
High-Performance Liquid Chromatography (HPLC). HPLC
(Agilent HP 1100 Series System, Germany) was carried out using a
Supelco Ascentis Express C18 (Sigma, U.K.). The mobile phase
consisted of 0.1% TFA in water and 0.085% TFA in acetonitrile, and a
ﬂow rate of 2.0 mL/min was used. The samples were analyzed at 255.9
nm.
Variable-Temperature X-ray Power Diﬀraction (VT-XRPD). VT-
XRPD experiments (Bruker D8 Advance, Bruker, U.K.) data sets were
collected from 5.0° to 30.0° at 2θ under nitrogen purge with a ﬂow
rate of approximately 50 mL/min and 99.9% purity. The sample was
placed in an Anton-Paar TTK450 (Anton-Paar, Austria) chamber at 25
°C. The temperature was controlled by a Temperature Control Unit
TCU 100 (Anton-Paar, Austria), and the applied heating rate was set
by default to 0.167 K·s−1. Diﬀractograms were recorded during heating
at 25, 50, 75, 100, and 110 °C, and cooling at the same temperatures as
during heating. The sample was maintained under isothermal
conditions for diﬀerent periods of time at each temperature, according
to the knowledge provided by preliminary studies.
Unit cell parameters were determined by Pawley reﬁnement of the
collected patterns using the software TOPAS-Academic.20 The initial
values of the cell parameters for the reﬁnement at 25 °C were taken
from the single crystal structure of Form I. Reﬁnements of powder
patterns at higher temperatures were initiated from cell parameters
reﬁned in the previous heating or cooling step. The pattern recorded
at 100 °C during cooling was indexed by ﬁtting 20 peaks between 2Θ
= 6.5−20.5° in DASH21and indexing them using DICVOL.22 All peaks
were successfully indexed with M(20) = 39.2.
■ RESULTS
Thermoanalytical Investigation of the Dehydration
Process. The thermal behavior of paroxetine HCl Form I was
investigated by DSC using three types of pans: pinhole,
hermetic, and open. As presented in Figure 4, the type of pan
used has a profound eﬀect on the thermal response observed.
As expected, it was found that the accurate melting point of
Form I has to be measured in hermetic pans (in order to avoid
dehydration) and has an onset temperature of 142.0 ± 0.2 °C,
which is in agreement with the reported value in the
literature.16 However, when pinhole and open pans were
used, the onset melting temperature of Form I was shifted to
lower temperatures and appeared as a broad and poorly
resolved proﬁle.
The eﬀect of the heating rate (HR) (2, 5, 10, 20, and 50 °C/
min) was tested using the three types of pans (data not shown).
In pinhole pans, as the heating rate increased, the peaks became
broader and, at 50 °C/min, the melting event was shifted closer
to the melting of the hydrate Form I. The results obtained at
diﬀerent HRs with hermetic pans were the same at all the
heating programs used. With open pans, a signiﬁcant
dependence on heating rate was observed, with slower rates
indicating a distinct endotherm that we associate with a
Figure 4. DSC traces of paroxetine HCl Form I at 10 °C/min in hermetic, pinhole, and open pans.
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dehydration process (supported by TGA studies as discussed
later).
The thermal response of paroxetine HCl Form II under
similar experimental conditions (pan type and heating rate) was
fully investigated in our previous work.7 We found that Form II
dehydrated in open pans (Figure 5), whereas, in hermetic
conditions, Form II transformed on heating to the stable Form
I (Supporting Information, Figure SI 1).
Figure 5 shows the DSC responses of paroxetine HCl Forms
I and II in open pans (2 °C/min) so as to highlight the
diﬀerences in behavior between the two forms studied under
identical conditions. First of all, the water loss was detected at
diﬀerent temperature ranges for the two forms. In the case of
Form II, the water loss started from the beginning of the run,
whereas, for Form I, the loss occurred roughly between 50 and
100 °C. The onset melting temperature was detected at 111.9
± 0.4 °C for Form I and at 117.5 ± 0.4 °C for Form II,
resulting in a diﬀerence of almost 6 °C between the onset
melting points of these two forms, while the peak melting
temperatures diﬀered by almost 3 °C. At this early stage of the
investigation, these results, while not conclusive, indicated that
there may be diﬀerences in the anhydrate forms generated from
the dehydration of the two hydrate forms.
We then investigated the conditions required to dehydrate
Form I, working on the assumption that the anhydrate (I)
could be identiﬁed by a melting point onset of ca. 112 °C.
Surprisingly, the only means of producing this form was within
the DSC, with storage over P2O5 or oven drying both resulting
in only partial dehydration (Table 1). Preliminary studies
indicated that a functioning water ﬁlter on the nitrogen supply
was also essential (data not shown), further reinforcing the
hypothesis that the environment must be extremely dry to
allow dehydration of Form I to occur. This also led to the
consideration that physical isolation of the anhydrate was
extremely diﬃcult, as any exposure to humidity resulted in
reconversion. Consequently, all our subsequent studies involve
the assessment of the structure within the instrument used to
generate the anhydrate.
In contrast, Form II was completely dehydrated inside the
DSC, when held isothermally in the oven or stored over P2O5.
Complete dehydration of Form II was conﬁrmed by the
detection of a single endotherm event corresponding to the
melting of the dehydrated Form II (≈117 °C). Overall, this set
of comparative experiments suggested that the dehydration of
Form II is a much simpler process than the dehydration of
Form I, able to happen over a wider range of conditions with a
more stable product being generated.
Another important aspect in this study was to ensure that the
complete dehydration of paroxetine HCl Form I was not
associated with any amorphization of the sample. Therefore, a
heat−cool−heat procedure was set up at 2 °C/min using open
pans. We noticed during the second heating cycle a broad
Figure 5. DSC traces of paroxetine HCl Forms I and II when heated in open pans at 2 °C/min.
Table 1. Dehydration Studies of Paroxetine HCl Form I and Form II Performed at Diﬀerent Drying Conditions
sample experimental drying procedure Tm onset (°C) ΔHmelting (J/g) Tm peak (°C)
Form I DSC open pans 111.9 ± 0.4 50.4 ± 1.4 120.4 ± 0.1
aoven 100 °C/24 h 136.7 ± 0.8 85.2 ± 0.2 140.9 ± 0.1
aP2O5/48 h 138.9 ± 0.9 91.5 ± 2.4 141.1 ± 1.5
Form II DSC open pans 117.5 ± 0.4 53.1 ± 1.0 123.1 ± 0.1
aoven 100 °C/1 h 116.6 ± 0.2 56.2 ± 2.0 120.1 ± 0.3
aP2O5/48 h 117.2 ± 0.9 53.2 ± 0.2 120.5 ± 1.7
aMeasurements were made in hermetic pans. All the experiments were performed at 2 °C/min.
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endothermic transition between 40 and 60 °C (Supporting
Information, Figure SI 2). The ﬁrst assumption made was that
this transition could be a glass transition event as a
consequence of amorphization after dehydration. However,
the transition was not observed on the reversing heat ﬂow
signal, which then excluded this hypothesis. The possibility of
this transition being an artifact was eliminated, with the same
results being obtained either using pans from diﬀerent batches
or the same procedure carried out using diﬀerent DSC
instruments. At this point, the most likely explanation for the
transition was water evaporation. However, as the DSC cell is a
closed system, the only possible source of moisture would be
the nitrogen purge gas. We, therefore, suggest that, even with a
water ﬁlter, the system is suﬃciently hygroscopic to pick up
water, probably via surface sorption as there was no evidence of
regeneration of the hydrate form. This further demonstrates the
experimental diﬃculties associated with handling such a
hygroscopic sample.
Given the above results, it was considered important to
evaluate the strength of the interactions between the water and
the drug within the hydrate, which may be achieved using TGA.
In Figure 6, the DSC and TGA thermograms of paroxetine HCl
Form I have been overlaid. For a particular slow HR of 2 °C/
min, the water loss commenced at around 50 °C and occurred
continuously until approximately 115 °C; the loss can be
divided in two main temperature regions. The ﬁrst one between
50 and 95 °C covered the majority of the water loss and the
second one near the endothermic melting event, as we can
observe from the DSC curve.
The water content of the raw Form I was determined by
KFT to be 2.71 ± 0.25% w/w. This value was in a good
agreement with the designation of this form as the hemihydrate,
0.56 ± 0.05 mol of water per mole of drug and matched the
total weight lost measured by TGA (2.59 ± 0.04% w/w). In
addition, HPLC was used to conﬁrm that dehydration and the
subsequent melting process did not yield to any degradation of
the sample. Analyses were performed on the untreated
paroxetine HCl Form I and on the sample heated in the
TGA until 130 °C. No sign of degradation was found on the
heated sample (purity of 99.6%) when compared to the raw
Form I (purity of 99.5%).
A closer inspection of the derivative curve shows that, at a
HR of 2 °C/min, part of the water (0.61% of the 2.59%) can
only be released at high temperatures, i.e., near the melting
point of the dehydrated Form I. However, this idea was not
supported by the isothermal experiments, as shown in Figure 7.
For example, when the sample was kept at 90 °C, the
dehydration was completed after 30 min. The TGA isothermal
experiments were also important to access the dehydration
conditions when performing VT-XRPD, though a direct
correlation could not be made due to the environmental
diﬀerences between the two techniques.
Figure 6. DSC (−) and TGA (---) thermographs for paroxetine HCl Form I in open pans at 2 °C/min. The derivative weight curve (−·−·−) is
presented for clarity.
Figure 7. Representation of the conversion fraction (αt) versus time
obtained from TGA isothermal data at the diﬀerent temperatures.
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Dehydration Kinetics. Model-free analysis was performed
using nonisothermal data, allowing the calculation of the
activation energy, Ea, as a function of the conversion fraction,
αT. On the basis of the graphical shape of the isothermal curves,
as shown (Figure 7), the dehydration rate decreases as the
reaction proceeds, and thereby, the kinetic model for this
reaction is known as decelerating. There are three other major
groups of kinetic models described in the literature as
accelerating, linear, and sigmoidal.14 Both isothermal and
nonisothermal methods have advantages and disadvantages.
The main issue encountered with isothermal methods is the
unavoidable nonisothermal heat-up to the set up isothermal
temperature. On the other hand, the biggest disadvantage of
nonisothermal experiments is the diﬃculty in diﬀerentiating
between acceleratory and sigmoidal models.14,23
The Ea for the dehydration of paroxetine HCl Form I was
calculated using a nonisothermal isoconversional method
developed by Ozawa, Flynn, and Wall24,25 and, therefore,
commonly referred to as the OFW method, which can be
expressed by eq 3
β
α
= − −AE
g R
E
RT
log log
( )
0.457 2.315
T
a a
(3)
where β is the heating rate, g(αT) is the integral reaction model,
and R is the gas constant.
Plotting log β versus 1000/T at each αT yields Ea from the
slope. Figure 8 shows the variation of the Ea as a function of the
conversion fraction (αT).
By analyzing in more detail the dependence of Ea with αT
through the kinetic reaction, as shown in Figure 8, a decrease in
the Ea from 114.1 to 99.2 kJ/mol within 0.15 ≤ αT ≤ 0.40,
followed by an approximately constant value of 85.9−96.2 kJ/
mol in the range of 0.45 ≤ αT ≤ 0.75, can be observed. The
initial decrease of the Ea vs αT is characteristic of reversible
reactions and could indicate a departure from the initial
equilibrium.14 After this nearly constant period, the Ea started
to increase gradually until an abrupt high value (211.8 kJ/mol)
when αT = 0.9. This increase in the Ea for the ﬁnal conversion
fractions can be linked to the observations in TGA, showing
that the removal of the ﬁnal fractions of water took place at
higher temperatures, therefore, requiring more energy.
However, one should also bear in mind that a loss of linearity
and a higher error are expected at the ﬁnal points of αT,
weakening the correlation with the TGA results. Nevertheless,
this variation of Ea with αT indicates that the process is
kinetically complex and a single-step rate equation cannot
describe the whole reaction.
Attempts to analyze isothermal data using model-free
methods were unsuccessful since good correlations could
only be obtained for high values of conversion (αt ≥ 0.40) as
the rate of the reaction is faster in the beginning (decelerating
model). As a result, there is a signiﬁcant extent of conversion
during the heat-up time even using an HR of 50 °C/min to
quickly reach the desired isothermal temperature.
The acquired knowledge up to this stage allowed us to
understand the thermal behavior of Form I when exposed to
diﬀerent dehydration conditions and carefully set up the XRPD
experiments, as follows, which are essential to provide
information on the structure of the dehydrated form.
Structural Studies Using VT-XRPD. VT-XRPD experi-
ments of Form I were performed in a closed system constantly
purged with dry nitrogen gas in order to mimic the conditions
inside the DSC and TGA furnaces. A change in the XRPD
pattern started to be apparent after 1 h at 75 °C, with some of
the diﬀraction peaks becoming broader. The changes were
clearly observed as the temperature increased (Figure 9). After
5 h isothermal treatment at 100 °C, the existing peaks became
less sharp and new peaks appeared, which may be associated
with the departure of the water molecules and the concomitant
appearance of a new phase. This phenomenon was more
evident when the temperature increased to 110 °C, and the
sample was kept isothermal for 12 h. After that time, and
analyzing the spectrum at lower angles, it is possible to
distinguish the new peaks that appeared (∗) and the peaks from
the hydrated Form I that started to disappear (#). However, at
higher angles, the discrimination between the two phases is
more diﬃcult due to the overlap between some of the peaks.
Pawley reﬁnement20 using the unit cell parameters of Form I
gave a good ﬁt to the experimental patterns at temperatures
below 75 °C, but at 100 and 110 °C, the ﬁt was very poor due
Figure 8. Activation energy, Ea, plotted as a function of the extent of
conversion, αT, for the dehydration of paroxetine HCl Form I under
nonisothermal conditions.
Figure 9. VT-XRPD diﬀractograms collected on paroxetine HCl Form
I at 25, 50, 75, 100, and 110 °C (upward). Peaks identiﬁed with (∗)
correspond to the new anhydrous form, and those identiﬁed with (#)
are related to the initial Form I.
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to the presence of more than one form (Supporting
Information, Figure SI 3 and Table SI 1).
On cooling, it was possible to index the pattern collected
after 1 h at 100 °C as a single phase. Pawley reﬁnement with
the new unit cell parameters from indexing gave a good ﬁt to
the diﬀraction pattern. The reﬁned cell parameters (a =
14.400(2) Å, b = 10.5362(15) Å, and c = 12.7706(13) Å) were
found to be very similar to those of the hemihydrate Form I at
75 °C (a = 14.655(5) Å, b = 10.191(3) Å, and c = 13.039(5)
Å), but with a smaller unit cell volume. The space group of the
new anhydrous form (I) was found to be P21, the same as Form
I. A similar pattern to the one collected at 100 °C was
maintained on further cooling down to 50 °C (Figure 10).
When the temperature dropped to 25 °C, the pattern changed
signiﬁcantly, which might be ascribed to the re-entry of water
molecules into the crystal structure. At this stage, the ﬁtting
using the anhydrous (I) unit cell parameters became very poor,
as the pattern started gradually to revert to the initial Form I.
Figure 11 presents, for comparison, the patterns collected at
50 °C on heating and at the same temperature on cooling. As
we can see, the two XRPD patterns at this temperature were
diﬀerent, conﬁrming that the observed changes were not owing
to thermal expansion but to the presence of two diﬀerent
crystalline forms (hydrated Form I on heating and dehydrated
Form I on cooling).
Figure 12 depicts the changes in the unit cell volume as a
function of temperature. It is clear that, during heating, the unit
cell volume increased slightly, as expected for thermal
expansion. The unit cell volume of the new form at 50 °C
was found to be 56 Å3 smaller than that of Form I at the same
temperature, which is consistent with dehydration (Table SI 1).
After 6 h at 25 °C, the unit cell volume was found to be the
same as that of the hydrate Form I, indicating that full
rehydration took place.
From these observations, we can suggest that Form I
dehydrated to an isostructural anhydrous form. Although we
were unable to determine the structure of the dehydrated form
(I), the similarity of its unit cell parameters to the hydrated
structure allows a tentative explanation for its instability.
Removal of the water molecules from the hemihydrate (Figure
2) requires a signiﬁcant rearrangement of strong hydrogen
bonds, which explains why high temperature and low RH are
required for dehydration. Since the powder patterns are similar,
the resulting structure is expected to show limited changes and
is most probably restricted to small shifts of the molecules
relative to each other. The hydrogen bonds involving water
molecules in the hydrate need to be replaced by ammonium−
chloride hydrogen bonds in the anhydrate (I). It is apparent
from Figure 2 that it is impossible to fully satisfy the acceptor
capacity of chloride ions within the constraints of limited
molecular rearrangement, and even those bonds that can form
may well induce steric strain. Consequently, the anhydrate (I)
structure is expected to be highly unstable and react with water
easily.
Finally, by comparing the pattern obtained for the
dehydrated Form II at 30 °C/1% RH obtained from our
previous work7 and the pattern collected in this study at 50 °C
for the dehydrated Form I, we can see that these two crystalline
patterns are diﬀerent (Figure 13). As Form II forms an
isostructural anhydrate when dehydrated, only shifts on the
diﬀraction peaks were observed without any changes in terms
of appearance/disappearance of peaks. Attempts to ﬁt the
Figure 10. VT-XRPD patterns of paroxetine HCl Form I collected
during cooling from 110 to 25 °C (upward). At 25 °C, the
diﬀractograms were collected after 1, 2, and 6 h isothermal at that
temperature.
Figure 11. VT-XRPD data collected on heating (hydrated Form I)
and on cooling (dehydrated Form I) at 50 °C, upward.
Figure 12. Changes in the unit cell volume of paroxetine HCl Form I
during heating at 25, 50, 75, and 100 °C (⧫); during cooling of the
anhydrous form (●) at the same temperatures as during heating; and
after cooling at 25 °C for 6 h (□). Note that Form I was heated to 110
°C; however, indexing was not possible at this temperature. The
reﬁnement at 100 °C on heating and after 1 h at 25 °C on cooling gave
a poor ﬁtting; thus, these results are less reliable.
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pattern of dehydrated Form I using the unit cell parameters of
the dehydrated Form II were unsuccessful, reinforcing the
hypothesis that these two dehydrated forms are structurally
diﬀerent.
■ DISCUSSION
The combination of thermal and diﬀraction techniques allowed
investigation of the dehydration behavior of paroxetine HCl
Form I and, consequently, suggested the existence of a new
anhydrous form as a result of this process. Dehydration was ﬁrst
observed when Form I was heated in pinhole or open pans in
the DSC. However, the melting peak temperature observed for
the dehydrated Form I (120 °C) was fairly close to the melting
of the isostructural dehydrate Form II (123 °C), which made
the diﬀerentiation between these two dehydrated forms diﬃcult
using thermal techniques.
Therefore, VT-XRPD experiments were performed in a
closed system blanket with dry nitrogen gas (99.9% purity) in
similar conditions as those observed in the DSC and TGA
furnaces. The changes in the XRPD pattern started to be
observed as the temperature increased, with the appearance of
new diﬀraction peaks after the sample was kept isothermal for 5
h at 100 °C. The Pawley reﬁnement showed that the unit cell
parameters of the new anhydrous form (I) were very similar to
those of the hydrate Form I, the main diﬀerence being a smaller
unit cell volume, as a result of dehydration. Therefore, we can
conclude that Form I dehydrates to an isostructural dehydrate
form.
During cooling, as a result of the temperature drop, residual
moisture in the N2 source (in theory around 1%), and probably
not completely hermetically sealed VT chamber, the pattern
started gradually to revert to the initial Form I after 1 h at 25
°C. Pawley reﬁnement using the pattern collected after 6 h at
25 °C showed that the unit cell had the same volume as the
hydrate Form I, conﬁrming that the new anhydrous form fully
rehydrated to Form I. The structural rehydration observed
during cooling in the VT-XRPD experiments was supported by
the results obtained when the sample was cycled inside the
DSC in open pans, with the dehydrate Form I picking up
moisture from the nitrogen gas.
The dehydration kinetic studies of Form I were conducted
using nonisothermal TGA data with a view to estimate the Ea
required to dehydrate Form I. Model-free analysis was used to
calculate the Ea for dehydration of Form I, which varies
between 86 and 114 kJ/mol. This value of Ea is much higher
than the reported value (60 kJ/mol) for stable hydrates under
ambient conditions,26 supporting again the great stability
observed for the hydrate Form I.
Figure 14 is a schematic representation of the relationships
between hydrated and dehydrated forms of paroxetine HCl.
Form II dehydrated to an isostructural anhydrous form that
rehydrated back at 10−30% RH (data presented in our
previous work7). The dehydration of Form I was a more
complex process, implying a completely dry environment and
high temperatures. The dehydrated Form I was found to be
very unstable with quick reconversion to the hydrate Form I
when RH ≈ 1%. The two dehydrated forms of Forms I and II
were structurally diﬀerent, and therefore, a new form of
paroxetine HCl has been found.
The signiﬁcance of these ﬁndings lies not only in the
identiﬁcation of a new structure for an important drug molecule
but also in highlighting the complexity of dehydration and
rehydration behavior of low molecular weight molecules. The
Form I anhydrate was extremely diﬃcult to produce and isolate
due to the high resistance to dehydration and extreme aﬃnity
for water. The anhydrate (I) is extremely unstable and hence is
not a viable candidate for commercial use. However, taken in
the context of the unusual hydration behavior of Form II
highlighted in our previous study,7 this drug also serves as a
potentially highly important model for understanding the
relationship between chemical structure and hydration
behavior. In particular, the current study has highlighted the
extreme aﬃnity of the dehydrated Form I for water, which is in
itself of interest in understanding hydrate formation and
stability.
■ CONCLUSIONS
In this study, we have shown that the dehydration of paroxetine
HCl Form I is a complex and uncommon process for a
stoichiometric hydrate. The prepared anhydrous form (I) is
structurally diﬀerent from the dehydrated Form II; thereby, a
new anhydrous form of paroxetine HCl has been identiﬁed.
Moreover, the structure of the new anhydrous form (I) was
found to be very similar to that of the hydrate Form I, which
supported its high instability and tendency to quickly rehydrate.
These ﬁndings are of considerable relevance on the under-
standing of the solid-state relationships of paroxetine HCl.
Furthermore, the study presents new insights into the behavior
of hydrates with high resistance to dehydration, with the
possibility of new forms being identiﬁed and enhanced
understanding of the driving factors determining hydrate
formation and stability.
Figure 13. VT-XRPD pattern of the dehydrated Form I at 50 °C on
cooling (bottom) and VH-XRPD pattern of the dehydrated Form II
(top) collected at 30 °C/1% RH (data collected from ref 7).
Figure 14. Representative scheme of the relationship between the two
forms of paroxetine HCl.
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